RADIATION PROTECTION DOSIMETRY is a vital academic journal dedicated to the field of radiation protection, published by Oxford University Press. With an ISSN of 0144-8420 and an E-ISSN of 1742-3406, this journal serves as a platform for groundbreaking research and developments in dosimetry, health physics, and radiation safety spanning over four decades since its inception in 1981. Recognized with a Q3 ranking in multiple categories including Medicine (miscellaneous) and Public Health, this journal plays a key role in disseminating important findings that inform policy, enhance practice, and promote the protection of both individuals and the environment from radiation hazards. While currently not available as Open Access, the journal's curated content is essential for researchers, professionals, and students dedicated to advancing knowledge in radiation protection and related areas. Interested readers will find the latest research trends, case studies, and reviews invaluable for their work and studies within this multidisciplinary domain.

RADIOPROTECTION, published by EDP SCIENCES S A, stands as a pivotal journal in the multidisciplinary fields of Nuclear Energy, Public Health, and Environmental Safety. With an ISSN of 0033-8451 and an E-ISSN of 1769-700X, this journal delves into the crucial aspects of radiation protection and its interactions with health and environment, providing a platform for researchers and professionals to disseminate their findings and insights. Despite being classified in the Q4 quartile for Health, Toxicology and Mutagenesis in 2023, its Q3 status in prestigious categories such as Nuclear Energy and Engineering, and Public Health, underscores its relevance in contemporary academic discourse. The journal continues to expand its cachet with converged years of publication from 1977 to 1981 and 1988 to 2024, ensuring a rich history of scholarly contributions. Access options for interested readers include traditional subscriptions, allowing for comprehensive engagement with a broad range of topics surrounding safety, sustainability, and risk management. Whether you are a researcher, professional, or student, RADIOPROTECTION serves as an essential resource for expanding understanding and fostering innovation within its field.

Journal of Radiation Research and Applied Sciences, published by ELSEVIER, is a premier open-access journal since 2013, dedicated to advancing the understanding and application of radiation research in various fields. With an ISSN of 1687-8507, this journal serves as a vital resource for researchers, professionals, and students engaged in the study of the physical and biological effects of radiation, radiation physics, and its applications in medicine and industry. Its rigorous peer-review process ensures the dissemination of high-quality research that meets the growing demands for innovative solutions in radiation science. By offering comprehensive access options, the journal promotes an inclusive approach to sharing knowledge with the global community. The Journal of Radiation Research and Applied Sciences stands out as a key platform for scholarly communication, fostering advancements that impact both theory and practice in the rapidly evolving landscape of radiation research.

International Journal of Radiation Oncology Biology Physics, published by Elsevier Science Inc, is a premier academic journal that has played a critical role in advancing the field of radiation oncology since its inception in 1975. With an impressive impact factor and recognition as a Q1 journal across multiple categories such as Cancer Research, Oncology, and Radiology, this journal serves as a vital resource for researchers, clinicians, and students dedicated to understanding and improving cancer treatment modalities. Its multifaceted scope encompasses original research, reviews, and innovative clinical studies, fostering a deeper understanding of the interplay between radiation, biology, and oncology. With a remarkable ranking in Scopus, including a top position in Radiation Physics and an elite percentile in Oncology, IJROBP remains at the forefront of scientific discovery and innovation in the management of cancer. A traditional subscription model ensures high-quality, peer-reviewed content, providing invaluable insights that continue to advance the standards of care and research in radiation oncology.

HEALTH PHYSICS is a leading academic journal dedicated to the study and dissemination of knowledge in the fields of radiology, epidemiology, and health toxicology. Published by Lippincott Williams & Wilkins, this esteemed journal has been a cornerstone of research since its inception in 1958, and it continues to foster important discussions and advancements in the discipline. With a notable impact factor and consistently ranking in the Q2 and Q3 quartiles across various categories in 2023, HEALTH PHYSICS serves as a vital resource for scholars, practitioners, and students seeking the latest insights and methodologies in the management of radiation exposure and its health implications. While the journal does not offer open access, it remains a critical platform for peer-reviewed articles that contribute to public health and environmental safety. The journal's comprehensive scope and historical significance underscore its importance in advancing knowledge and practices within its field, making it an essential read for anyone engaged in the multidisciplinary realms of health physics.

RADIATION PHYSICS AND CHEMISTRY, published by Pergamon-Elsevier Science Ltd in the United Kingdom, stands as a leading journal in the field of radiation studies, bridging fundamental research and practical applications. With an impressive 2023 Scopus Rank of 11 out of 58 in the Radiation category, reflecting an 81st percentile ranking, the journal maintains a robust reputation within the scientific community. The journal focuses on the experimental and theoretical aspects of radiation physics, chemistry, and their interdisciplinary applications, providing critical insights that aid the advancement of knowledge in various domains, including nuclear energy, materials science, and healthcare. Although open access options are not available, the journal garners substantial readership and engagement from researchers, professionals, and students alike, as it publishes innovative studies and reviews from 1985 through to its anticipated conclusion in 2025. The ISSN for the journal is 0969-806X, with the E-ISSN being 1879-0895, ensuring global accessibility to cutting-edge research in radiation science.

NUKLEONIKA, published by SCIENDO, is a leading open access journal that has been serving the scientific community since its establishment in 1968. Focused on the domains of Nuclear and High Energy Physics, Condensed Matter Physics, and Nuclear Energy and Engineering, this journal provides a platform for innovative research and technological advancements in a variety of interdisciplinary fields. With an impressive history of publications and a current Q3 ranking in several categories, including Safety, Risk, Reliability and Quality and Waste Management and Disposal, NUKLEONIKA is recognized for its significant contributions to scientific discourse. Open access since 2014, the journal ensures that all research outputs are freely available, facilitating broad dissemination and accessibility for researchers, professionals, and students alike. Located in the heart of Warsaw, Poland, NUKLEONIKA aims to inspire collaborative efforts and foster a deeper understanding of complex physical phenomena and their practical implications.

STRAHLENTHERAPIE UND ONKOLOGIE is an esteemed journal published by Springer Heidelberg, focusing on critical advancements and research in the fields of Oncology and Radiology. Established in 1986, this journal has carved its niche within the scientific community, ranking in the Q1 category for Radiology, Nuclear Medicine and Imaging, and Q2 for Oncology as of 2023. With an ISSN of 0179-7158 and E-ISSN 1439-099X, it serves as an essential resource for researchers, professionals, and students dedicated to the complexities of cancer treatment and radiation therapy. While the journal operates under a subscription model, its broad international readership values its rigorous peer-review process and comprehensive coverage of pivotal studies. STRAHLENTHERAPIE UND ONKOLOGIE continues to enhance its impact in the domains of oncology and radiology, as evidenced by its commendable Scopus rankings, including a 76th percentile in Radiology and a 65th percentile in Oncology. Its commitment to disseminating innovative research solidifies its role as a cornerstone in the ongoing quest to improve patient care and therapeutic techniques.

RADIATION RESEARCH is a prestigious journal published by the RADIATION RESEARCH SOC that serves as a vital resource for professionals and researchers in the fields of biophysics, radiation science, and radiology. Established in 1954, this journal has consistently advanced the study of radiation's effects on health and the environment, bridging fundamental and applied research. It boasts an impressive impact factor reflected in its quartile rankings, including Q2 in Biophysics and Q1 in Radiation, making it a highly regarded publication within its discipline. Researchers will find valuable insights through rigorous peer-reviewed articles that explore innovative methodologies and findings related to radiation exposure, imaging technologies, and the biological consequences of radiation. Although the journal does not currently offer open access, it remains a vital reference for academia and industry, fostering a deeper understanding of radiation sciences and their implications for future research and public health.

Practical Radiation Oncology is a premier journal published by Elsevier Science Inc., focusing on the critically important fields of Oncology and Radiology, Nuclear Medicine, and Imaging. With an ISSN of 1879-8500, this journal serves as an essential resource for professionals and researchers dedicated to advancing the practice and research of radiation oncology. Established in 2011 and continuing through 2024, it has quickly gained recognition, achieving a prestigious Q2 ranking in Oncology and an exceptional Q1 ranking in Radiology, Nuclear Medicine, and Imaging as of 2023. The journal, housed in New York, USA, provides a platform for innovative research and practical insights, aimed at enhancing therapeutic practices and improving patient outcomes. As part of its commitment to fostering scientific dialogue, it also features a range of articles, reviews, and clinical studies that cater to the diverse interests of its readers. Hard-copy availability combined with digital access ensures a broad reach for the latest advancements in the field.